New therapy aims to ease emotional toll of testicular cancer in young latino men
NCT ID NCT07615998
First seen Jun 27, 2026 ยท Last updated Jun 27, 2026
Summary
This pilot study tested a 6-session therapy called Goal-Focused Emotion Regulation Therapy (GET) in 35 young Latino testicular cancer survivors aged 18-39. The therapy helps participants set goals, manage emotions, and find meaning after cancer. Researchers measured anxiety, depression, and goal navigation skills at the start, after treatment, and at a 3-month follow-up.
What this could mean
Our plain-language read of the trial. This is informational only โ not medical advice or a prediction.
- Active substance
- Goal-focused emotion regulation therapy (GET) - a 6-session behavioral intervention
- What this could lead to
- If it works, this could provide a simple, culturally tailored therapy to help young Latino testicular cancer survivors manage anxiety and depression.
- What could go wrong
- This is a very small pilot study with only 35 participants and no comparison group, so results may not apply broadly. The therapy may not produce lasting benefits.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TESTICULAR CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of California, Irvine
Irvine, California, 92697, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Hidden heart risks in testicular cancer survivors: a closer look at chemotherapy's long shadow
- Glowing dye could reveal hidden cancer spread in testicular tumors
- New chemo cocktail targets Hard-to-Treat testicular cancer
- Could a safer scan replace standard CT for testicular cancer Follow-Up?
- Can a psoriasis drug tame Immunotherapy's harsh side effects?
- Virtual reality could help young cancer survivors navigate life after treatment